<DOC>
	<DOCNO>NCT00240799</DOCNO>
	<brief_summary>The purpose study evaluate acetaminophen extend release ( 3900 mg/day ) compare placebo safety effectiveness relief sign symptom osteoarthritis hip knee 12 week</brief_summary>
	<brief_title>An Effectiveness Safety Study Acetaminophen Extended Release Caplets Treatment Osteoarthritis Hip Knee .</brief_title>
	<detailed_description>This randomize , double-blind , placebo control study evaluate acetaminophen extend release 3900 mg/day compare placebo relief sign symptom osteoarthritis hip knee 12 week . The hypothesis 3900 mg/day acetaminophen extend release superior placebo relief sign symptom osteoarthritis hip knee respect three primary effectiveness endpoint . Propoxyphene Hydrochloride Capsules , 65 mg , use rescue medication subject experience inadequate pain relief . The primary efficacy assessment average change baseline Week 12 WOMAC pain subscale score WOMAC physical function subscale score , subject 's average global assessment response therapy Week 12 . Safety assessment study visit consist monitor adverse event , vital sign , study joint assessment clinical laboratory determination . Treatment consist two acetaminophen 650 mg extend release caplets two placebo caplets , administer orally every 8 hour 12 week .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Symptoms osteoarthritis hip knee minimum six month History hip knee pain due osteoarthritis require use NSAIDs , acetaminophen another analgesic agent regular basis ( &gt; = three days/week ) least three month screen visit History positive benefit acetaminophen use osteoarthritis pain History ( ie , time past since diagnosis ) osteoarthritis pain hip knee take osteoarthritis analgesic medication Subjects must report history pain level moderate , moderately severe , severe , WOMAC pain score &gt; = 65 baseline , 20 % great increase pain score relative score screen History surgery , include arthroscopy , major trauma study joint previous six month screen visit Grade 1 grade 4 severity study joint base Kellgren Lawrence radiographic criterion Signs clinically important active inflammation study knee joint include redness , warmth , and/or large , bulge effusion loss normal contour screen and/or baseline visit Secondary osteoarthritis study joint include , limited , septic arthritis , inflammatory joint disease , gout , Paget 's disease bone , articular fracture , major dysplasia congenital abnormality , ochronosis , acromegaly , hemochromatosis , Wilson 's disease , avascular necrosis , primary osteochondromatosis History acute inflammatory arthritis pseudogout study joint .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>osteoarthritis hip</keyword>
	<keyword>osteoarthritis knee</keyword>
	<keyword>acetaminophen</keyword>
</DOC>